CVRx/CVRX

$19.98

-5.75%
-
1D1W1MYTD1YMAX

About CVRx

CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.

Ticker

CVRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Kevin Hykes

Employees

200

Headquarters

Minneapolis, United States

CVRx Metrics

BasicAdvanced
$447.85M
Market cap
-
P/E ratio
-$1.99
EPS
-
Beta
-
Dividend rate

What the Analysts think about CVRx

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 4 analysts.
62.66% upside
High $35.00
Low $30.00
$19.98
Current price
$32.50
Average price target

CVRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-80.53% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$11.3M
7.62%
Net income
$-9.1M
1.11%
Profit margin
-80.53%
-6.04%

CVRx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 19.24%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.44
-
-
-
-
Expected
-$0.54
-$0.54
-$0.49
-$0.47
-$0.43
Surprise
-19.24%
-
-
-
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell CVRx stock

Buy or sell CVRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing